unique physique tirzepatide is excited to share an update on the latest FDA guidelines for Tirzepatide. We’re pleased to announce that we’re still offering this treatment for both new and existing patients Looking to transform your body

Read the full announcement: #ObesityWeek #OW2025 To view or add a comment, sign in Real-world results speak volumes

Semaglutide is a GLP-1 receptor agonist , while Tirzepatide activates both GLP-1 and GIP receptors , enhancing fat metabolism and insulin release

Further, the novel formula combines state-of-the-art encapsulation with unique ingredients like peptides, probiotics, doze, NMN, and more

First, accumulating evidence has shown that the expression and function of key efferocytosis receptors, MerTK (183), LRP1 (184), and SR-BI (185) are impaired in advanced atherosclerosis

Diabetic retinopathy worsening Rapid improvements in blood glucose with GLP-1s can be linked to a temporary worsening of diabetic retinopathy in those with pre-existing advanced eye disease

The tablets are easy to swallow and dont have any aftertaste